Harder,U. et al., Chemische Berichte, 1964, vol. 97, p. 510 - 519
作者:Harder,U. et al.
DOI:——
日期:——
US9776962B2
申请人:——
公开号:US9776962B2
公开(公告)日:2017-10-03
AROMATIC COMPOUND
申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US20160115128A1
公开(公告)日:2016-04-28
Provided is a novel aromatic ring compound having a GPR40 agonist activity and a GLP-1 secretagogue action. A compound represented by the formula:
wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity and a GLP-1 secretagogue action, is useful for the prophylaxis or treatment of cancer, obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia and the like, and affords superior efficacy.